FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207417970> ?p ?o ?g. }

• W3207417970 abstract "Abstract Background Peripheral artery disease (PAD) is highly prevalent in people with type 2 diabetes and associates with chronic limb ischemia and poor prognosis. Understanding the mechanisms of impaired blood vessel growth in diabetic patients is of paramount importance to develop new angiogenic therapies in this setting. Dysregulation of epigenetic mechanisms of gene transcription in vascular cells contributes to cardiovascular disease development but is currently not targeted by therapies. Apabetalone (RVX-208) – an FDA approved small molecule inhibitor of the epigenetic readers bromodomain and extra-terminal (BET) proteins – has recently shown to modulate transcriptional programs implicated in vascular inflammation and atherosclerosis. Purpose To investigate RVX-208 effects in modulating angiogenic response and post-ischemic vascularization in diabetes. Methods Primary human aortic endothelial cells (HAECs) were exposed to normal glucose (NG, 5 mM) or high glucose (HG, 20 mM) for 48 hours in presence of RVX-208 (20μM) or vehicle (DMSO). Scratch and tube formation assays were performed to investigate the impact of RVX-208 on angiogenic properties of HAECs. T1D mice (streptozotocin-induced diabetes) and T2D mice (Lepdb/db) were orally treated with apabetalone or vehicle for 5 days. Hindlimb ischemia was induced in T1D mice & blood flow recovery analysed at 30 minutes, 7 and 14 days by laser Doppler imaging. Sprouting and matrigel plug assays were performed in Lepdb/db mice. Gastrocnemius muscle samples from patients with and without T2D were employed to translate our experimental findings. Results HG impaired HAECs migration and tube formation as compared to NG, whereas treatment with RVX-208 rescued HG-induced impairment of angiogenic properties. Real time PCR arrays in HG-treated HAECs showed that RVX-208 treatment prevents the dysregulation of genes implicated in endothelial migration, sprouting and inflammation, namely the anti-angiogenic molecule thrombospondin (THBS1), VEGF-A, IL-1β, IL-6, VCAM-1, and CXCL1. Of interest, both gene silencing of BET protein (BRD4) or its pharmacological inhibition by RVX-208 reduced THBS1 expression while restoring VEGFA levels in HG-treated HAECs. ChIP assays showed the enrichment of both BRD4 and the active chromatin mark H3K27Ac on THBS1 promoter. Mechanistic experiments uncovered the inhibitory role of THBS1 on VEGFA signalling, as also confirmed by STRING analysis. Treatment of T1D mice with RVX-208 improved blood flow reperfusion and vascular density at 14 days as compared to vehicle-treated animals. Moreover, RVX-208 restored endothelial sprouting in T2D-Lepdb/db mice. Of clinical relevance, THBS1 was upregulated while VEGFA expression was reduced in gastrocnemius muscle specimens from T2D patients with PAD as compared to non-diabetic controls. Conclusion In vivo targeting of BET-proteins by RVX-208 may represents a novel therapeutic approach to boost post-ischemic neovascularization in diabetes. FUNDunding Acknowledgement Type of funding sources: Public Institution(s). Main funding source(s): University of Zurich" @default.
• W3207417970 created "2021-10-25" @default.
• W3207417970 creator A5001228217 @default.
• W3207417970 creator A5018218619 @default.
• W3207417970 creator A5024381247 @default.
• W3207417970 creator A5026282759 @default.
• W3207417970 creator A5031442314 @default.
• W3207417970 creator A5033415494 @default.
• W3207417970 creator A5063037284 @default.
• W3207417970 creator A5085049522 @default.
• W3207417970 creator A5087471697 @default.
• W3207417970 date "2021-10-01" @default.
• W3207417970 modified "2023-10-03" @default.
• W3207417970 title "The BET protein inhibitor apabetalone (RVX-208) restores angiogenic response in type 1 and type 2 diabetes by transcriptional regulation of thrombospondin-1" @default.
• W3207417970 doi "https://doi.org/10.1093/eurheartj/ehab724.3384" @default.
• W3207417970 hasPublicationYear "2021" @default.
• W3207417970 type Work @default.
• W3207417970 sameAs 3207417970 @default.
• W3207417970 citedByCount "0" @default.
• W3207417970 crossrefType "journal-article" @default.
• W3207417970 hasAuthorship W3207417970A5001228217 @default.
• W3207417970 hasAuthorship W3207417970A5018218619 @default.
• W3207417970 hasAuthorship W3207417970A5024381247 @default.
• W3207417970 hasAuthorship W3207417970A5026282759 @default.
• W3207417970 hasAuthorship W3207417970A5031442314 @default.
• W3207417970 hasAuthorship W3207417970A5033415494 @default.
• W3207417970 hasAuthorship W3207417970A5063037284 @default.
• W3207417970 hasAuthorship W3207417970A5085049522 @default.
• W3207417970 hasAuthorship W3207417970A5087471697 @default.
• W3207417970 hasBestOaLocation W32074179701 @default.
• W3207417970 hasConcept C126322002 @default.
• W3207417970 hasConcept C134018914 @default.
• W3207417970 hasConcept C2777180221 @default.
• W3207417970 hasConcept C2780394083 @default.
• W3207417970 hasConcept C541997718 @default.
• W3207417970 hasConcept C555293320 @default.
• W3207417970 hasConcept C71924100 @default.
• W3207417970 hasConcept C98274493 @default.
• W3207417970 hasConceptScore W3207417970C126322002 @default.
• W3207417970 hasConceptScore W3207417970C134018914 @default.
• W3207417970 hasConceptScore W3207417970C2777180221 @default.
• W3207417970 hasConceptScore W3207417970C2780394083 @default.
• W3207417970 hasConceptScore W3207417970C541997718 @default.
• W3207417970 hasConceptScore W3207417970C555293320 @default.
• W3207417970 hasConceptScore W3207417970C71924100 @default.
• W3207417970 hasConceptScore W3207417970C98274493 @default.
• W3207417970 hasIssue "Supplement_1" @default.
• W3207417970 hasLocation W32074179701 @default.
• W3207417970 hasOpenAccess W3207417970 @default.
• W3207417970 hasPrimaryLocation W32074179701 @default.
• W3207417970 hasRelatedWork W1966504330 @default.
• W3207417970 hasRelatedWork W1974041167 @default.
• W3207417970 hasRelatedWork W1979139803 @default.
• W3207417970 hasRelatedWork W2003150205 @default.
• W3207417970 hasRelatedWork W2037631372 @default.
• W3207417970 hasRelatedWork W2127396703 @default.
• W3207417970 hasRelatedWork W2132898409 @default.
• W3207417970 hasRelatedWork W2153591790 @default.
• W3207417970 hasRelatedWork W2158288207 @default.
• W3207417970 hasRelatedWork W2748952813 @default.
• W3207417970 hasVolume "42" @default.
• W3207417970 isParatext "false" @default.
• W3207417970 isRetracted "false" @default.
• W3207417970 magId "3207417970" @default.
• W3207417970 workType "article" @default.